This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 1986;256(13):1778-1783.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The appearance of acquired immunodeficiency syndrome (AIDS) has brought suffering and death to those who are afflicted and, at the same time, has posed daunting challenges to those who care for the sufferers, to biomedical scientists, and to those responsible for public health and public policy. Among these challenges is the protection of the nation's blood supply from contamination by the causative agent of AIDS—human immunodeficiency virus (previously referred to as human T-cell lymphotropic virus type III [HTLV-III]/lymphadenopathy-associated virus and subsequently referred to in this document as HIV in accordance with emerging and recommended usage). This challenge was met rapidly by the development of laboratory tests to detect the presence of antibody against the virus. The application of these tests makes it possible to determine whether the person has been infected by the virus at some time and, thus, to exclude persons from donating blood or to discard blood already . . . [Full Text PDF of this Article]

Footnotes
From the Office of Medical Applications of Research, National Institutes of Health, Bethesda, Md.

Reprint requests to Office of Medical Applications of Research, Bldg 1, Room 216, National Institutes of Health, Bethesda, MD 20205 (Michael J. Bernstein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?